Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies

Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies

Stem Cell Research & Therapy, 2019 · DOI: https://doi.org/10.1186/s13287-019-1357-z · Published: July 11, 2019

Spinal Cord InjuryRegenerative Medicine

Simple Explanation

Spinal cord injuries are hard to heal. Stem cells can turn into different kinds of cells, including nerve cells, and might help by becoming new nerve cells, protecting existing cells, or reducing swelling. Many types of stem cells are being studied for use in spinal cord injuries. Stem cells can replace damaged cells, reduce inflammation, and release helpful substances that improve the environment and encourage tissue regeneration. Stem cell therapy is considered the most promising treatment in regenerative medicine.

Study Duration
Not specified
Participants
Not specified
Evidence Level
Review

Key Findings

  • 1
    NSCs can differentiate into neurons to replace lost ones, creating relay circuits to bridge disrupted tracts, and secrete growth-promoting factors.
  • 2
    MSCs release anti-inflammatory factors and cytokines, improving the microenvironment and promoting self-repair.
  • 3
    ESCs can differentiate into neurons and glial cells to supplement cell defects caused by SCI, while also secreting factors to inhibit further damage and support nerve tissue regeneration.

Research Summary

Stem cell therapy shows promise for spinal cord injury repair, but challenges remain before clinical application. ESCs face ethical and tumorigenicity concerns, while iPSCs, though avoiding ethical issues, raise questions about the safety of gene transfer. MSCs have advantages in reducing inflammation and promoting blood supply but have limited differentiation potential, making them less ideal for severe chronic injuries.

Practical Implications

Targeted treatment strategies

Clinicians need to consider the specific SCI conditions to choose the most appropriate stem cell therapy.

Comprehensive Treatment Plans

Combining stem cell therapy with biological materials and drugs is crucial for maximizing treatment effects.

Preclinical Study Refinement

Preclinical studies should be adjusted based on the species of the experimental animals.

Study Limitations

  • 1
    Ethical issues and tumorigenicity of ESCs.
  • 2
    Safety concerns regarding exogenous gene transfer in iPSCs.
  • 3
    Limited differentiation potential of MSCs for severe chronic injuries.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury